{"id":"W2602605464","doi":"10.1182/blood-2017-01-761973","title":"Venetoclax and obinutuzumab in chronic lymphocytic leukemia","year":2017,"lang":"en","type":"letter","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Venetoclax; Obinutuzumab; Chronic lymphocytic leukemia; Chlorambucil; Medicine; Internal medicine; Fludarabine; Ibrutinib; Leukemia; IGHV@; Oncology; Bendamustine; Immunology; Chemotherapy; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001820517,0.000732569,0.00122252,0.0006458992,0.001734759,0.001882142,0.001428193,0.02116946,0.002751653],"category_scores_gemma":[0.009986148,0.0004313403,0.000766864,0.0007222349,0.001637494,0.00207999,0.0007036622,0.01699987,0.00248296],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002759805,"about_ca_system_score_gemma":0.001495792,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009814552,"about_ca_topic_score_gemma":0.001588764,"domain_scores_codex":[0.998757,0.0004918168,0.0001435781,0.0001342118,0.0002785669,0.0001947754],"domain_scores_gemma":[0.9972129,0.001632224,0.0002681778,0.00007537945,0.0004099895,0.0004012548],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002839917,0.0001295643,0.001875939,0.0002470852,0.00006107977,0.03287495,0.000175254,0.0003043925,0.0004962832,0.003654664,0.9291386,0.03075823],"study_design_scores_gemma":[0.0007084989,0.000382857,0.003247079,0.0008470561,0.0001672682,0.05678098,0.000563466,0.002125449,0.00105319,0.01252744,0.9214921,0.0001046864],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.003427153,0.01024747,0.0001858059,0.9388155,0.04423594,0.00002406024,0.00006162223,0.00005280761,0.002949664],"genre_scores_gemma":[0.03541043,0.01109551,0.0004131246,0.7223424,0.2232549,0.00005480813,0.00007030125,0.00003998492,0.007318715],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.02116946,"threshold_uncertainty_score":0.02002382,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02331277208653235,"score_gpt":0.2935193183196323,"score_spread":0.2702065462331,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}